medicalxpress.com
Researchers have developed new tumor models that closely resemble human neuroblastoma, promising advances in pediatric oncology.
The development of advanced tumor models that mirror human neuroblastoma tumors represents a significant breakthrough in pediatric cancer research, allowing for more accurate study and testing of treatments.
Researchers at Karolinska Institutet have advanced the fight against pediatric cancer by developing preclinical models that closely resemble human neuroblastoma. Utilizing single-cell RNA sequencing, they have created ex vivo tumoroid models that provide an accurate reflection of tumor complexity. These new models pave the way for high-throughput drug screening and personalized treatment strategies, holding promise for more effective pediatric cancer therapies.
Current preclinical models often lack accuracy in mirroring human tumor complexities. The development of models that accurately reflect human tumors is crucial for advancing cancer therapy. Without accurate models, research may fail to translate into effective treatments for patients, especially in complex cases like neuroblastoma.
"One of the biggest barriers in creating new cancer therapies is the development of preclinical models that accurately reflect human disease," explained Bethel Embaie, a Ph.D. student involved in the research.
Advanced single-cell techniques enhance understanding of the tumor microenvironment. Single-cell RNA sequencing provides unprecedented insights into tumor biology, facilitating the development of more accurate models. By understanding the tumor microenvironment at a cellular level, researchers can create models that better mirror human tumors.
The researchers employed single-cell RNA sequencing to dissect tumor tissues at a high resolution. This technique enables the identification of diverse cellular and molecular components within the tumor microenvironment. These findings are crucial for understanding the interactions between different cell types within tumors, which is important for developing treatments that target not just the tumor cells but also their supportive environments.
Accurate tumor models can lead to personalized treatment strategies for pediatric cancers. The development of ex vivo tumoroid models allows for personalized treatment approaches. Ex vivo models that replicate patient-specific tumor characteristics can be used for drug screening, leading to personalized therapies. The creation of ex vivo tumoroid models that faithfully replicate patient tumors marks a significant advancement.
"These advancements will not only accelerate the discovery of effective cancer therapies but also bring us closer to personalized treatment strategies for pediatric tumors," said Bethel.
The potential for personalized medicine in pediatric oncology could transform treatment outcomes, offering hope for more effective and targeted therapies.
Embaie, B. T., et al. (2025). Comparative Single-Cell Transcriptomics of Human Neuroblastoma and Preclinical Models Reveals Conservation of an Adrenergic Cell State. Cancer Research. DOI: 10.1158/0008-5472.CAN-24-1507
Science X. (n.d.). Editorial Process. Retrieved January 15, 2025, from https://sciencex.com/help/editorial-process/
Science X. (n.d.). Editorial Standards. Retrieved January 15, 2025, from https://sciencex.com/help/editorial-standards/